This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-03 and is reviewed periodically as new material appears.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
=== Primary ion source === Three types of ion source are used for SSIMS: electron-impact ionization, surface ionization, or liquid-metal ion sources. In the electron-impact ion source, electrons from a heated filament (cathode) are accelerated towards an anode by a voltage difference where they ionize supply-gas atoms on impact. This source usually operates with noble gases. Typically, the energy is variable from 0.1–5 keV, allowing spot sizes from ~50 μm to several millimeters. Surface ionization sources use Cs+ as the primary beam sources for TOF SIMS. Evaporation of caesium from a heated tungsten surface occurs both as atoms and ions. These ions are then accelerated away from the emitting surface. Since no collisions are involved, the ion beam is very pure, and since evaporation is by thermal means, the energy spread is very small, ~2kT (0.2 eV). The low energy spread and high intrinsic brightness of the ion sources offers the possibility of obtaining small spot sizes. Liquid-metal ion sources draw a liquid metal (usually gallium or bismuth) from a heated reservoir over a tip (radius ≈5 μm) of a needle. An electrostatic field is produced at the tip by an extraction electrode biased negatively in front of the tip. Opposing electrostatic and surface-tension forces acting on the liquid film produce a conical shape with a high-radius-of-curvature cusp (≈2 μm) protruding from the tip. From this cusp field, ion emission occurs, by means of the process of field evaporation.
=== HIV/AIDS === Baricitinib has been investigated for its potential to reduce the HIV reservoir and chronic inflammation in people infected with HIV. Preclinical studies in humanized mice and non-human primates have demonstrated that the drug can penetrate the blood-brain barrier and reach therapeutic concentrations in the central nervous system (CNS). In these models, baricitinib was associated with a reduction in cellular activation markers, lower frequencies of infected macrophages in the brain, and improvements in HIV-associated behavioral deficits. Research suggests that by blocking the JAK-STAT signaling pathway, the drug may limit the survival of infected cells and prevent the reseeding of viral reservoirs in sanctuary sites like the CNS, which are often poorly reached by standard antiretroviral therapy (ART). As of 2025, baricitinib is currently being evaluated in multiple Phase II clinical trials to assess its safety and efficacy as an adjunctive therapy to ART. One primary area of focus is its ability to decrease or clear the CNS reservoir, with ongoing trials monitoring changes in cerebrospinal fluid (CSF) viral DNA and neurocognitive function. Additional studies are examining its impact on systemic inflammation, cell survival pathways, and the delay of viral rebound during monitored treatment interruptions.
== Editorial and advisory roles == Eke serves on the editorial boards of several peer-reviewed journals. He is a member of the editorial board of NEJM Evidence, a journal published by the New England Journal of Medicine, as well as Frontiers in Global Women's Health (Infectious Diseases in Women), and the Journal of Maternal Health, Neonatology and Perinatology. He has also contributed to global health policy and ethics initiatives. Eke serves as a member of the World Health Organization (WHO) HIV, Hepatitis, and Sexually Transmitted Infections (STIs) Pregnancy and Breastfeeding Therapeutics Working Group (HHS PTWG), and has participated in working groups and committees convened by the National Academies of Sciences, Engineering, and Medicine focused on improving the inclusion of pregnant and lactating women in clinical research. His work has helped shape guidelines related to maternal pharmacology and public health policy.
HPTLC has also been used successfully in the separation of various lipid subclasses, with reproducible and promising results obtained for 20 different lipid subclasses. Numerous reports related to clinical medicine studies have been published in various journals. As a result, HPTLC is now strongly recommended for drug analysis in serum and other tissues.
Sources: en.wikipedia.org
An alkane has only C–H and C–C single bonds. The former result from the overlap of an sp3 orbital of carbon with the 1s orbital of a hydrogen; the latter by the overlap of two sp3 orbitals on adjacent carbon atoms. The bond lengths amount to 1.09 × 10−10 m for a C–H bond and 1.54 × 10−10 m for a C–C bond. The spatial arrangement of the bonds is similar to that of the four sp3 orbitals—they are tetrahedrally arranged, with an angle of 109.47° between them. Structural formulae that represent the bonds as being at right angles to one another, while both common and useful, do not accurately depict the geometry.
Forklifts as a pulley to raise and lower their fork carriage Chainsaws as cutting chains, which superficially resemble roller chains but are more closely related to the leaf chain. They are driven by projecting drive links which also serve to locate the chain onto the bar.
pasta bread cookies snacks (chips, nachos) smoothies Cricket flour can be utilized as a complete replacement for flour. The taste is described as very nutty, and foods normally prepared with wheat flour may cook differently.
glutamate (reduced nicotinamide adenine dinucleotide) synthase, glutamate synthase (NADH), L-glutamate synthetase(NADH), NADH-dependent glutamate synthase, NADH-glutamate synthase, and NADH-Glutamine oxoglutarate aminotransferase (NADH-GOGAT).
=== Leadership === Roger D. Cone began his tenure as the Mary Sue Coleman Director of the University of Michigan Life Sciences Institute in September 2016. A leading researcher in brain regulation of body weight, Cone also serves as vice provost and director of U-M's biosciences initiative. The managing director is Anna Schork. The institute's first director was Jack E. Dixon. In 2002, Mary Sue Coleman, U-M's president, appointed cell biologist and expert on insulin signaling Alan R. Saltiel as director. Saltiel served as the director until 2015, followed by interim director Stephen Weiss, who led the institute from 2015 to 2016.
Sources: en.wikipedia.org
==== Analysis and appreciation ==== Birzer, Bradley J. Cultural Repercussions: An In-Depth Examination of the Words, Ideas and Professional Life of Neil Peart, Man of Letters. Wordfire Press, 2015. ISBN 1614753547. Bowman, Durrell and Berti, Jim. Rush and Philosophy: The Heart and Mind United. Open Court Press, 2011. ISBN 978-0812697162. Bowman, Durrell. Experiencing Rush: A Listener's Companion. Rowman & Littlefield Publishers, 2014. ISBN 1442231300. Freedman, Robert. Rush: Life, Liberty, and the Pursuit of Excellence. Algora Pub, 2014. ISBN 1628940840. McDonald, Chris. Rush, Rock Music, and the Middle Class: Dreaming in Middletown. Indiana University Press, 2009. ISBN 0-253-22149-8. Mobley, Max. Rush FAQ: All That's Left to Know About Rock's Greatest Power Trio. Backbeat Books, 2014. ISBN 1617134511. Popoff, Martin. Rush: Album by Album. Voyageur Press, 2017. ISBN 978-0760352205. Price, Carol S. and Robert M. Price. Mystic Rhythms: The Philosophical Vision of Rush. Wildside Press, 1999. ISBN 1-58715-102-2. Roberto, Leonard. A Simple Kind Mirror: The Lyrical Vision of Rush. Iuniverse Star, 2000. ISBN 0595213626. Telleria, Robert. Rush Tribute: Merely Players. Quarry Press, 2002. ISBN 1-55082-271-3.
Distinguished Unit Citations: 15 Medal of Honor: 4 Private John R. Towle(KIA) Private First Class Charles N. Deglopper(KIA) First Sergeant Leonard A. Funk Jr. Private Joe Gandara(KIA) (issued 18 March 2014) Distinguished Service Cross: 37 Distinguished Service Medal: 2 Silver Star: 898 Legion of Merit: 29 Soldier's Medal: 49 Bronze Star Medal: 1,894 Air Medal: 15
==== Adequacy of equipment and regulations ==== The factory was not well equipped to handle the gas created by the sudden addition of water to the MIC tank. The MIC tank alarms had not been working for four years and there was only one manual back-up system, compared to a four-stage system used in the United States. The flare tower and several vent gas scrubbers had been out of service for five months before the disaster. Only one gas scrubber was operating: it could not treat such a large amount of MIC with sodium hydroxide (caustic soda), which would have brought the concentration down to a safe level. The flare tower could only handle a quarter of the gas that leaked in 1984, and moreover it was out of order at the time of the accident. To reduce energy costs, the refrigeration system was idle. The MIC was kept at 20 degrees Celsius, not the 4.5 degrees advised by the manual. Even the steam boiler, intended to clean the pipes, was non-operational for unknown reasons. Slip-blind plates that would have prevented water from pipes being cleaned from leaking into the MIC tanks if the valves had been faulty were not installed and their installation had been omitted from the cleaning checklist. As MIC is water-soluble, deluge guns were in place to contain escaping gases from the stack. The water pressure was too weak for the guns to spray high enough to reach the gas which would have reduced the concentration of escaping gas significantly. In addition to it, carbon steel valves were used at the factory, even though they were known to corrode when exposed to acid.
The September 11 attacks, colloquially known as 9/11, were a coordinated series of suicide attacks perpetrated by the Islamic terrorist organization al-Qaeda against the United States in 2001. A total of 19 hijackers commandeered four commercial passenger airliners. The first two planes were flown into each of the Twin Towers at the World Trade Center in New York City, while the third plane crashed into the Pentagon, the headquarters of the United States Department of Defense, in Arlington County, Virginia. The fourth plane crashed in a rural field in Pennsylvania during a passenger revolt. The ringleader, Mohamed Atta, flew American Airlines Flight 11 into the North Tower of the World Trade Center at 8:46 a.m. At 9:03 a.m. Marwan al-Shehhi flew United Airlines Flight 175 into the South Tower. Both collapsed within an hour and forty-two minutes, destroying the remaining five structures in the complex. Hani Hanjour flew American Airlines Flight 77 into the Pentagon at 9:37 a.m., causing a partial collapse. United Airlines Flight 93, hijacked by Ziad Jarrah, was believed to target either the United States Capitol or the White House. Alerted to the previous attacks, the passengers revolted and the hijackers crashed the aircraft into a field near Shanksville, Pennsylvania, at 10:03 a.m. The Federal Aviation Administration ordered a ground stop for all traffic in U.S. airspace, requiring all airborne aircraft to return to their point of origin or divert to Canada.
=== Priori Development and the ERIAD Controversy === John Fenn's development of electrospray ionization was preceded by the ERIAD method, a direct analogue created by Lidija Gall's group in the Soviet Union. Gall's team recorded mass spectra of peptides and proteins as early as 1981. During a 1983 visit to the Soviet Union, Fenn visited Lidija Gall's laboratory and engaged in "fruitful discussions" regarding her ERIAD method, which he described as "very promising". Although Gall published her findings in April 1984, which was five months before Fenn's first paper on the subject, her work remained largely unknown internationally for decades due to the "Iron Curtain". Despite this direct exposure to the technology and his comment that he would "try it in his lab," Fenn's subsequent 1984 publication did not cite Gall's earlier pioneering work. Gall's pioneering contributions were later recognized by the Nobel Committee in 2002 and through her receipt of the Thomson Medal in 2022.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
Dry powder is usually held frozen, shielded from light, and kept away from moisture. Desiccant packaging limits hydrolysis during storage. Solutions are typically aliquoted and frozen once, because repeated thawing shortens useful life.